[1]
Briz Martín, M.L., Zarzuelo Castañeda, A. and Sanchez Avila, A. 2018. Development and evaluation of a 0,01% atropine ophthalmic formulation. FarmaJournal. 3, 1 (Mar. 2018), 133–142.